Tuesday, August 2, 2011

Impax profit falls in Q2

Generic drug maker Impax Laboratories Inc. reported lower sales and profits in the second quarter than a year ago.
The Hayward company (NASDAQ: IPXL) earned $12.5 million in the June quarter, down from $31.3 million a year earlier. Sales fell to $125.9 million, down from $153.1 million a year earlier.

No comments:

Post a Comment